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Nosocomial infections, particularly those caused
by multiresistant microorganisms that are diffi-
cult to treat, are one of the main causes of concern
for those working in infectious diseases. They are
also an excellent indication of the quality of
hospital care. The present supplement to Clinical
Microbiology and Infection deals with five selected
microorganisms, primarily from a European per-
spective, that, overall, are responsible for a high
proportion of nosocomial infections that are very
difficult to treat.
In the first paper, Helen Giamarellou discusses
the clinical and laboratory problems resulting
from infections caused by Gram-negative bacilli
with the ability to produce extended-spectrum
b-lactamases; these are responsible for endemic
and epidemic infections, occurring mainly in
facilities for the care of critically ill patients, but
also of concern in general medical and surgical
wards. The relation of these outbreaks to the use
and misuse of broad-spectrum cephalosporins is
thoroughly addressed in this article.
Another paper, by Gian Maria Rossolini and
Elisabetta Mantengoli, is devoted to Gram-nega-
tive non-fermenting microorganisms, particularly
to Pseudomonas aeruginosa, with different and
multiple mechanisms of antimicrobial resistance.
These microorganisms constitute a very difficult
therapeutic problem that frequently requires the
use of old and obsolete antimicrobial agents,
almost unknown to younger physicians.
Methicillin-resistant Staphylococcus aureus
(MRSA) is responsible for infections with a
variable and very irregular distribution through-
out Europe. In some European centres, mainly in
intensive care units and in areas for the care of
high-risk patients, more than 50% of all S. aureus
causing severe infections are MRSA. Formerly a
nosocomial problem for the most part, MRSA
is also becoming a cause of concern in the
community owing to the presence of particularly
virulent strains with the ability to produce severe
infections with epidemic potential involving nor-
mal, previously uncompromised hosts. This sub-
ject is approached from the perspective of the
other side of the Ocean, according to the experi-
ence of Burke Cunha. The potential introduction
of these community strains into the hospital
setting could manifest as another horrifying scen-
ario in our institutions.
Vancomycin-resistant Enterococcus is a problem
with a higher incidence in the USA than in
Europe, for reasons not totally understood. Ellen
Mascini and Marc Bonten review, in depth, the
situation with this pathogen: its frequency, the
means of diagnosis, the therapeutic approach and
the mechanisms for control.
Finally, Clostridium difficile-associated diarrhoea
(CDAD) deserves a final paper. CDAD is a
frequent and severe problem in most institutions,
and a consequence of the widespread use of
antimicrobial agents, particularly of those inactive
against Clostridium. It constitutes a very important
cause of morbidity as well as prolonged hospital
stay and the increased costs implied, and is an
occasional cause of in-hospital death. We address
the present situation of CDAD, its diagnosis and
the therapeutic alternatives, in view of the recent
demonstration of antimicrobial resistance in
C. difficile against drugs of common use, such as
metronidazole.
As Guest Editors, we are grateful to the
European Society of Clinical Microbiology and
Infectious Diseases (ESCMID) and the European
Study Group for Nosocomial Infections (ESGNI)
for their invitation to coordinate this supplement,
and also to the staff of Clinical Microbiology and
Infection for their help at all times. If the readers
find the information useful and stimulating, we
will feel fully rewarded.
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